Number of the records: 1  

Selective Cyclin-Dependent Kinase Inhibitors Discriminating between Cell Cycle and Transcriptional Kinases Future Reality or Utopia?

  1. 1.
    SYSNO ASEP0335863
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleSelective Cyclin-Dependent Kinase Inhibitors Discriminating between Cell Cycle and Transcriptional Kinases Future Reality or Utopia?
    TitleSelektivní inhibitory CDK rozlišující kinasy regulující buněčný cyklus a transkripci: Realita nebo utopie?
    Author(s) Wesierska-Gadek, J. (AT)
    Kryštof, Vladimír (UEB-Q) RID, ORCID
    Source TitleNew York Academy of Sciences. Annals - ISSN 0077-8923
    Roč. 1171, - (2009), s. 228-241
    Number of pages14 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordscell cycle ; CYC202 ; cyclin-dependent kinase
    Subject RIVEB - Genetics ; Molecular Biology
    R&D ProjectsGA204/08/0511 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z50380511 - UEB-Q (2005-2011)
    UT WOS000269657300030
    DOI10.1111/j.1749-6632.2009.04726.x
    AnnotationProgression of the cell cycle is controlled by activating and inhibiting cellular factors. The delicate balance between these positive- and negative-acting regulators warrants proper cell cycle progression in normal cells and facilitates cellular response to a variety of stress stimuli. The increased activity of the positive regulators of the cell cycle in cancer cells is frequently accompanied by the loss or inactivation of the inhibitors of cyclin-dependent kinases (CDKs). The supplementation of the cellular CDK inhibitors by the pharmacological counterparts is a very promising therapeutic option. The generated pharmacological inhibitors of CDKs belong to different classes of compounds and display various CDK inhibitory features. In this article the action and specificity of CDK inhibitor roscovitine, belonging to the group of purine analogues, is reviewed and the rationale for dissecting the inhibitory action on cell cycle and transcriptional CDKs is discussed.
    WorkplaceInstitute of Experimental Botany
    ContactDavid Klier, knihovna@ueb.cas.cz, Tel.: 220 390 469
    Year of Publishing2010
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.